Sheila Shaigany, MD, FAAD
SESSIONS
U065 Inpatient Dermatology from Horses to Zebras: Lessons Learned at an Academic Hospital
Mar 9, 2025
•
8:00 AM - 12:00 AM
•
W204C
DISCLOSURES
Blueprint Medicines – Advisory Board(Honoraria); Boehringer Ingelheim – Advisory Board(Honoraria), Investigator(No Compensation Received); Hoth Therapeutics – Investigator(No Compensation Received); Priovant Therapeutics – Consultant (1099 relationship)(Honoraria), Investigator(No Compensation Received);